Adele Gulfo
Director/Board Member chez ENPRO INC.
Fortune : 791 489 $ au 31/03/2024
Profil
Adele M.
Gulfo is currently the Chief Executive Officer-Biopharma Commercial Unit at Sumitomo Pharma America, Inc. She is also an Independent Director at Enpro, Inc., Medexus Pharmaceuticals, Inc., and Myovant Sciences Ltd.
Additionally, she serves as a Board of Advisor at 1843 Capital LLC and as the Chief Business & Commercial Development Officer at Sumitovant Biopharma, Inc. In her former positions, Ms. Gulfo served as the Chairman-Commercial Development at Roivant Sciences Ltd.
from 2018 to 2019.
She was an Independent Director at Bemis Co., Inc. from 2015 to 2019.
She also held positions at Volunteers of America, Inc., The Committee of 200, Pfizer Inc. as the President-Latin America Region from 2009 to 2014, Mylan, Inc. as the EVP-Global Collaboration & Strategic Operations, and Mylan NV as the EVP & Head of Global Commercial Development from 2014 to 2018.
Ms. Gulfo obtained a graduate degree from the University of Medicine & Dentistry of New Jersey.
She also holds an MBA from Fairleigh Dickinson University and an undergraduate degree from Seton Hall University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ENPRO INC.
0,02% | 20/03/2024 | 4 293 ( 0,02% ) | 724 530 $ | 31/03/2024 |
22/09/2023 | 54 930 ( 0,22% ) | 66 960 $ | 31/03/2024 |
Postes actifs de Adele Gulfo
Sociétés | Poste | Début |
---|---|---|
ENPRO INC. | Director/Board Member | 30/10/2018 |
MEDEXUS PHARMACEUTICALS INC. | Director/Board Member | 25/06/2019 |
MYOVANT SCIENCES LTD. | Director/Board Member | 27/12/2019 |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/12/2019 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | Consultant / Advisor | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/07/2023 |
Anciens postes connus de Adele Gulfo
Sociétés | Poste | Fin |
---|---|---|
ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/12/2019 |
BEMIS COMPANY, INC. | Director/Board Member | 11/06/2019 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Corporate Officer/Principal | 01/01/2018 |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░ ░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Adele Gulfo
University of Medicine & Dentistry of New Jersey | Graduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Seton Hall University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
PFIZER, INC. | Health Technology |
ENPRO INC. | Producer Manufacturing |
ROIVANT SCIENCES LTD. | Health Technology |
MEDEXUS PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Bemis Co., Inc.
Bemis Co., Inc. Containers/PackagingProcess Industries Bemis Co., Inc. engages in the manufacture and sale of packaging for the food, healthcare, and pharmaceutical companies. It operates through the following segments: U.S. Packaging; Latin America Packaging; Rest of the World Packaging; and Corporate. The U.S. Packaging segment manufactures multilayer polymer, blown and cast film structures which are then converted to produce packaging for processed and fresh meat, dairy, liquids, frozen foods, cereals, snacks, cheese, coffee, condiments, candy, pet food, bakery, lawn and garden, tissue, fresh produce, personal care and hygiene, and agribusiness in the United States. The Latin America Packaging segment focuses in the production of multilayer polymer, blown, and cast film structures to produce packaging sold for a variety of food, medical, pharmaceutical, personal care, electronics, and industrial applications in Latin America. The Rest of World Packaging Segment comprises food and non-food packaging-related manufacturing operations located in Europe and Asia-Pacific as well as medical device and pharmaceutical packaging-related manufacturing operations in the U.S., Europe, and Asia. The company was founded by Judson Moss Bemis in 1858 and is headquartered in Neenah, WI. | Process Industries |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Volunteers of America, Inc.
Volunteers of America, Inc. Services to the Health IndustryHealth Services At Volunteers of America, Inc. provides housing and health care services. The firm provides human service programs, including housing and healthcare services. The company was founded on March 08, 1896 and is headquartered in Alexandria, VA. | Health Services |
The Committee of 200
The Committee of 200 Miscellaneous Commercial ServicesCommercial Services The Committee of 200 operates as a membership organization for women entrepreneurs and corporate innovators. | Commercial Services |
Myovant Sciences Ltd.
Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | Finance |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |